Hill-Rom Holdings (NYSE: HRC) and Exactech (NASDAQ:EXAC) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Valuation & Earnings

This table compares Hill-Rom Holdings and Exactech’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Hill-Rom Holdings $2.71 billion 1.87 $465.30 million $1.73 44.49
Exactech $262.96 million 1.67 $43.51 million $0.04 763.94

Hill-Rom Holdings has higher revenue and earnings than Exactech. Hill-Rom Holdings is trading at a lower price-to-earnings ratio than Exactech, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Hill-Rom Holdings and Exactech, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hill-Rom Holdings 0 1 4 0 2.80
Exactech 0 0 1 0 3.00

Hill-Rom Holdings presently has a consensus price target of $87.80, suggesting a potential upside of 14.09%. Given Hill-Rom Holdings’ higher probable upside, equities research analysts plainly believe Hill-Rom Holdings is more favorable than Exactech.


Hill-Rom Holdings pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Exactech does not pay a dividend. Hill-Rom Holdings pays out 41.6% of its earnings in the form of a dividend. Hill-Rom Holdings has raised its dividend for 6 consecutive years.

Volatility & Risk

Hill-Rom Holdings has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Exactech has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Institutional and Insider Ownership

82.3% of Hill-Rom Holdings shares are owned by institutional investors. Comparatively, 64.6% of Exactech shares are owned by institutional investors. 2.2% of Hill-Rom Holdings shares are owned by insiders. Comparatively, 28.3% of Exactech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.


This table compares Hill-Rom Holdings and Exactech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hill-Rom Holdings 4.27% 19.99% 5.73%
Exactech 0.30% 7.39% 5.98%


Hill-Rom Holdings beats Exactech on 12 of the 17 factors compared between the two stocks.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.

Exactech Company Profile

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.